These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 21749268)

  • 21. Eudraginated polymer blends: a potential oral controlled drug delivery system for theophylline.
    Emeje M; John-Africa L; Isimi Y; Kunle O; Ofoefule S
    Acta Pharm; 2012 Mar; 62(1):71-82. PubMed ID: 22472450
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Continuous direct compression as manufacturing platform for sustained release tablets.
    Van Snick B; Holman J; Cunningham C; Kumar A; Vercruysse J; De Beer T; Remon JP; Vervaet C
    Int J Pharm; 2017 Mar; 519(1-2):390-407. PubMed ID: 28069390
    [TBL] [Abstract][Full Text] [Related]  

  • 23. In vitro and in vivo sustained-release characteristics of theophylline matrix tablets and novel cluster tablets.
    Hayashi T; Kanbe H; Okada M; Kawase I; Ikeda Y; Onuki Y; Kaneko T; Sonobe T
    Int J Pharm; 2007 Aug; 341(1-2):105-13. PubMed ID: 17512147
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Development and Evaluation of Compression Coating Gastro-Floating Tablet of Alfuzosin Hydrochloride for Zero-Order Controlled Release.
    Gong L; Sun Y; Yu M; Gao Y; Zou M; Cheng G
    AAPS PharmSciTech; 2018 Oct; 19(7):3277-3286. PubMed ID: 30215168
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Modulation of microenvironmental pH for dual release and reduced in vivo gastrointestinal bleeding of aceclofenac using hydroxypropyl methylcellulose-based bilayered matrix tablet.
    Kang WH; Nguyen HV; Park C; Choi YW; Lee BJ
    Eur J Pharm Sci; 2017 May; 102():85-93. PubMed ID: 28263912
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Modulation of drug (metoprolol succinate) release by inclusion of hydrophobic polymer in hydrophilic matrix.
    Siddique S; Bose A; Khanam J
    Drug Dev Ind Pharm; 2011 Sep; 37(9):1016-25. PubMed ID: 21401340
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Formulation development of carvedilol compression coated tablet.
    Shah R; Patel S; Patel H; Pandey S; Shah S; Shah D
    Pharm Dev Technol; 2013; 18(4):906-15. PubMed ID: 21797662
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Assessment of the bioequivalence of two formulations of clarithromycin extended-release 500-mg tablets under fasting and fed conditions: a single-dose, randomized, open-label, two-period, two-way crossover study in healthy Jordanian male volunteers.
    Alkhalidi BA; Tamimi JJ; Salem II; Ibrahim H; Sallam AA
    Clin Ther; 2008 Oct; 30(10):1831-43. PubMed ID: 19014838
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Formulation and evaluation of controlled release matrices of ketoprofen and influence of different co-excipients on the release mechanism.
    Wahab A; Khan GM; Akhlaq M; Khan NR; Hussain A; Khan MF; Khan H
    Pharmazie; 2011 Sep; 66(9):677-83. PubMed ID: 22026123
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Formulation, release characteristics and bioavailability of novel monolithic hydroxypropylmethylcellulose matrix tablets containing acetaminophen.
    Cao QR; Choi YW; Cui JH; Lee BJ
    J Control Release; 2005 Nov; 108(2-3):351-61. PubMed ID: 16154656
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Development and Evaluation of a Once-Daily Controlled Porosity Osmotic Pump of Tapentadol Hydrochloride.
    Thakkar HP; Pancholi N; Patel CV
    AAPS PharmSciTech; 2016 Oct; 17(5):1248-60. PubMed ID: 26677859
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Lyophilized mucoadhesive-dendrimer enclosed matrix tablet for extended oral delivery of albendazole.
    Mansuri S; Kesharwani P; Tekade RK; Jain NK
    Eur J Pharm Biopharm; 2016 May; 102():202-13. PubMed ID: 26563727
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Physical properties and in vivo bioavailability in human volunteers of isradipine using controlled release matrix tablet containing self-emulsifying solid dispersion.
    Tran PH; Tran TT; Piao ZZ; Vo TV; Park JB; Lim J; Oh KT; Rhee YS; Lee BJ
    Int J Pharm; 2013 Jun; 450(1-2):79-86. PubMed ID: 23612354
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Preparation of Losartan Potassium Controlled Release Matrices and In-Vitro Investigation Using Rate Controlling Agents.
    Khan KA; Khan GM; Muzammal M; Al Mohaini M; Alsalman AJ; Al Hawaj MA; Ahmad A; Niazi ZR; Shah KU; Farid A
    Molecules; 2022 Jan; 27(3):. PubMed ID: 35164127
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Release characteristics and in vitro-in vivo correlation of pulsatile pattern for a pulsatile drug delivery system activated by membrane rupture via osmotic pressure and swelling.
    Lin HL; Lin SY; Lin YK; Ho HO; Lo YW; Sheu MT
    Eur J Pharm Biopharm; 2008 Sep; 70(1):289-301. PubMed ID: 18539015
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Differential pharmacokinetics of diclofenac potassium for oral solution vs immediate-release tablets from a randomized trial: effect of fed and fasting conditions.
    Chen C; Bujanover S; Kareht S; Rapoport AM
    Headache; 2015 Feb; 55(2):265-75. PubMed ID: 25546369
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Development of novel diclofenac potassium controlled release tablets by wet granulation technique and the effect of co-excipients on in vitro drug release rates.
    Shah S; Khan GM; Jan SU; Shah K; Hussain A; Khan H; Khan H; Khan H; Khan KA
    Pak J Pharm Sci; 2012 Jan; 25(1):161-8. PubMed ID: 22186325
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A single-dose, randomized, two-way crossover study comparing two olanzapine tablet products in healthy adult male volunteers under fasting conditions.
    Elshafeey AH; Elsherbiny MA; Fathallah MM
    Clin Ther; 2009 Mar; 31(3):600-8. PubMed ID: 19393850
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Near-infrared spectroscopic analysis of the breaking force of extended-release matrix tablets prepared by roller-compaction: influence of plasticizer levels and sintering temperature.
    Dave VS; Fahmy RM; Hoag SW
    Drug Dev Ind Pharm; 2015 Jun; 41(6):898-905. PubMed ID: 24785574
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Modulation of drug release by utilizing pH-independent matrix system comprising water soluble drug verapamil hydrochloride.
    Baviskar D; Sharma R; Jain D
    Pak J Pharm Sci; 2013 Jan; 26(1):137-44. PubMed ID: 23261739
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.